MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4103/ijp.ijp_333_18

Медицинская библиотека · Indian journal of pharmacology · 2020

Use of rituximab in muscle-specific tyrosine kinase antibody-positive myasthenia gravis: Preliminary observations from a tertiary care center in Northern India.

Sachdeva Julie, Mahesh Karthik Vinay, Shree Ritu, Jain Gaurav, Kapila Aastha Takkar, Shashikala Tirulapati Padmavathi, Goyal Manoj Kumar, Modi Manish, Lal Vivek

СтатьяНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVES

Approximately 10%-15% of patients with myasthenia gravis (MG) are refractory to standard treatment. A sizable chunk of these patients is due to muscle-specific tyrosine kinase (MuSK) antibody-positive MG which often runs a severe course with frequent relapses and poor response to conventional treatment. We report six patients with refractory MuSK-positive MG who responded well to the treatment with rituximab.

PATIENTS AND

METHODS

In this prospective institute-based observational study, we report six MuSK antibody-positive MG patients, who did not achieve remission with standard treatment and were later started on rituximab infusion.

RESULTS

There was a significant clinical improvement in all patients after starting rituximab.

CONCLUSION

Rituximab is an effective immunomodulatory therapy in MuSK antibody-positive MG patients who are not responding to the standard treatment.

Для цитирования: Sachdeva Julie, Mahesh Karthik Vinay, Shree Ritu, Jain Gaurav, Kapila Aastha Takkar, Shashikala Tirulapati Padmavathi, Goyal Manoj Kumar, Modi Manish, Lal Vivek. Use of rituximab in muscle-specific tyrosine kinase antibody-positive myasthenia gravis: Preliminary observations from a tertiary care center in Northern India.. Indian journal of pharmacology. 2020. DOI: 10.4103/ijp.ijp_333_18.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.